For patients with schizophrenia and breast cancer, adjuvant radiation therapy may not be preferable
the ONA take:
According to a new study published in The American Journal of Surgery, researchers have found that for patients with schizophrenia and breast cancer, initial radical surgery without adjuvant radiation therapy may be preferred. For the study, researchers sought to investigate how patients with schizophrenia who later develop breast cancer handle treatment with adjuvant radiation.
Researchers identified 40 patients with schizophrenia who later developed breast cancer and were candidates for adjuvant radiation therapy from the national computer database of the Department of Veterans Affairs. Results showed clinicians decided to offer adjuvant radiation therapy in 35 of 40 patients, but only offered it to 22 patients. Of those 22 patients, 23% refused treatment with adjuvant radiation therapy.
The findings suggest that patients with both schizophrenia and breast cancer do not fully comprehend their diseases. In addition, patients with schizophrenia are often non-compliant with recommended standard therapies, especially those that depend upon adjuvant radiation therapy. Therefore, the research suggest that strategies that involve conserving the breast may not be the best option, and initial radical surgery without the use of radiation may be better for the patient.
According to the National Institute of Mental Health, patients with schizophrenia often lack the ability to understand information and use that information to make decisions.
For patients with schizophrenia and breast cancer, initial radical surgery without radiation therapy preferred.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|